Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Two trans inmates ordered back to women’s prisons in Reagan-appointed judge’s injunction

by admin March 29, 2025
March 29, 2025
Two trans inmates ordered back to women’s prisons in Reagan-appointed judge’s injunction

Transgender inmates who were moved from a women’s prison to an all-male facility, after President Donald Trump’s executive order mandating inmates live in facilities corresponding to their biological sex, are now being sent back to the women’s prison after a judge issued a preliminary injunction.

‘This is the latest example of an activist judge attempting to seize power at the expense of the American people who overwhelmingly voted to elect President Trump,’ a Department of Justice (DOJ) spokesperson told Fox News Digital in a statement Friday. ‘The Department of Justice has vigorously defended President Trump’s executive actions, including the Defending Women Executive Order, and will continue to do so.’

U.S. District Judge Royce Lamberth in Washington issued the injunction last week after the two inmates, identified in court documents as Rachel and Ellen Doe, were added as plaintiffs to a lawsuit against Trump’s executive order with nearly a dozen other inmates.

‘The fact that they have already been transferred and, allegedly, have been abused at their new facilities can only strengthen their claims of irreparable harm,’ Lamberth, a Reagan-appointed U.S. district court judge, wrote in the injunction.

The court documents also allege that since being transferred to a male prison, ‘they have been unable to access bras and women’s underwear’ while being subjected to ‘sexual harassment’ at the new facilities.

The Bureau of Prisons did not respond when reached for comment Friday.

The original lawsuit the two new inmates were added to alleged that ‘the inmates, all of whom are transgender women, ‘will not be safe’ if transferred to men’s facilities, the lawsuit states, and the inmates will be at risk of ‘sexual harassment, assault, and rape.’

This injunction adds to a lengthy list of legal battles the Trump DOJ faces regarding the president’s executive orders. The first lawsuit against Trump’s ‘two sexes’ executive order came from a transgender inmate receiving taxpayer-funded medical treatments just days after Trump signed the order in January.

That inmate, anonymously identified as Maria Moe, is being represented by advocacy groups GLBTQ Legal Advocates & Defenders and National Center for Lesbian Rights and Lowenstein Sandler LLP. Once Trump signed the executive order, Moe was transferred to a men’s prison facility, and BOP records changed the sex from ‘female’ to ‘male,’ the complaint says.

At least 15 trans prisoners are now protected by orders blocking or reversing the transfers, the Associated Press reported.

Lamberth has not yet ruled on a lawsuit filed this month by three other inmates—a transgender woman in a men’s prison and two transgender men in women’s prisons—who are challenging the executive order’s ban on transgender medical treatments in prisons.

This post appeared first on FOX NEWS

previous post
Putin says Trump plans for Greenland ‘has nothing to do’ with Russia
next post
Trump doubles down on acquiring Greenland for ‘world peace’ amid Vance visit

Related Posts

Department of Justice opens criminal investigation into NY...

May 9, 2025

House witness flips script on Dem who ambushed...

June 8, 2025

Republicans consider using reconciliation again after Trump’s biggest...

December 24, 2025

Federal department cafeteria empty for years under Biden:...

February 21, 2025

Trump heads to Scotland, continues ironing out trade...

July 21, 2025

Judicial nominee shuts down ‘wildly inaccurate’ claims that...

June 26, 2025

James Comer to accuse Tim Walz of being...

January 7, 2026

Trump’s transgender military ban dealt legal blow after...

April 2, 2025

Rubio says US, Qatar on verge of finalizing...

September 16, 2025

Trump’s CDC pick confirmed—but her pro-vaccine stance may...

July 30, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved